But only one follicle – the largest and most well-developed – usually reaches ovulation, where the follicle ruptures like a ...

The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.

AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) ...

The pain was so bad I bent at the waist, gripping the table. At the front of the room, I told my students, “You are excused. I’m sorry, I’m very sick. I need to leave now.” The Cambodian staff of ...

The EC has approved Elahere for treating adult patients with folate receptor-alpha (FRα) positive, platinum-resistant and ...

AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...

ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

This basic research study presents useful data concerning the menstrual fluid composition and its potential for endometriosis biomarker research. However, despite solid bioinformatics analyses, the ...

The new drama tells the story of the world's first IVF baby through the eyes of the doctors who pioneered the treatment ...

The new Netflix offering looks to shine a light on Jean Purdy in an emotional performance by Thomasin McKenzie ...

A mum is sharing her harrowing ordeal after initially thinking she was going through the menopause – but then finding it was ...